Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy
Autor: | Eric Assenat, Daniel Verzilli, Georges-Philippe Pageaux, Margaux Hermida, Laure Escal, M A Pierredon-Foulongne, Lauranne Piron, Christophe Cassinotto, Boris Guiu, Samir Jaber |
---|---|
Přispěvatelé: | Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), MORNET, Dominique |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Ablation Techniques
Male Cancer Research Percutaneous Physiology Radiofrequency ablation 030218 nuclear medicine & medical imaging law.invention 0302 clinical medicine law Aged 80 and over Microwave ablation Liver Neoplasms food and beverages Pneumothorax hepatocellular carcinoma Middle Aged 3. Good health Treatment Outcome 030220 oncology & carcinogenesis Hepatocellular carcinoma Catheter Ablation Female [SDV.IB]Life Sciences [q-bio]/Bioengineering Radiology radiofrequency ablation Adult medicine.medical_specialty Carcinoma Hepatocellular Thermal ablation [SDV.CAN]Life Sciences [q-bio]/Cancer liver 03 medical and health sciences Dome (geology) [SDV.CAN] Life Sciences [q-bio]/Cancer Physiology (medical) otorhinolaryngologic diseases medicine Humans Aged Retrospective Studies [SDV.IB] Life Sciences [q-bio]/Bioengineering business.industry fungi [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology Carbon Dioxide medicine.disease [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology digestive system diseases microwave ablation business Dome |
Zdroj: | International Journal of Hyperthermia International Journal of Hyperthermia, Taylor & Francis, 2018, 35 (1), pp.90-96. ⟨10.1080/02656736.2018.1477206⟩ International Journal of Hyperthermia, 2018, 35 (1), pp.90-96. ⟨10.1080/02656736.2018.1477206⟩ |
ISSN: | 0265-6736 1464-5157 |
DOI: | 10.1080/02656736.2018.1477206⟩ |
Popis: | International audience; Introduction: The targeting of hepatocellular carcinomas (HCC) in the hepatic dome can be challenging during percutaneous thermal ablation (PTA). The aims of this study were (1) to evaluate the safety and efficacy of PTA of HCC in the hepatic dome that cannot be visualized under US, using artificial CO2 pneumothorax and CT-guidance and (2) to compare the results with US-visible HCC located in the liver dome treated under US-guidance.Materials: Over a 32-month period, 56 HCC located in the hepatic dome were extracted from a prospectively maintained database. Twenty-eight cases (US-guidance group) were treated under US-guidance, while the others (n = 28, CT-CO2 group) were treated under CT-guidance using artificial CO2 pneumothorax after lipiodol tagging of the tumor. The primary technical success and complications rates of this technique were retrospectively assessed. Local tumor progression (LTP), intrahepatic distant recurrence (IDR), local recurrence-free survival (LRFS) and overall survival (OS) were also compared between both groups.Results: Primary technical success was 100% in both groups. No major complications occurred. After a median follow-up of 13.8 months (range, 1–33.4 months), LTP occurred in 10.7% (3/28) in CT-CO2 vs. 25% (7/28) in the US-guidance group (p = NS). IDR occurred in 39.3% (11/28) in CT-CO2 vs. 28.6% (8/28) in the US-guidance group (p = NS). Death occurred in 17.9% (5/28) of patients in both groups. LRFS and OS did not significantly differ using Kaplan-Meier survival estimates.Conclusion: CT-guided PTA after artificially induced CO2 pneumothorax is a safe and efficient technique to treat HCC located in the hepatic dome. |
Databáze: | OpenAIRE |
Externí odkaz: |